ArticlePLoS computational biology2026
Integrating multi-type features and knowledge graph for graded prediction of drug-induced liver injury in humans.
Article in PLoS computational biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Drug-induced liver toxicity poses a threat to human health and remains a significant reason for drug withdrawal from the market. Therefore, early identification of drug-induced liver injury (DILI) during drug development is crucial. However, most studies on hepatotoxicity prediction are limited to single type of features or binary toxicity assessment. In this study, we propose a novel liver toxicity prediction model called MolFPKG-DILI (Molecular Graph, FingerPrint and Knowledge Graph-based DILI), which integrates multi-type compound features and knowledge graph for assessing DILI severity. Molecular fingerprints and molecular graphs capture different information of compounds, and models using individual features alone have shown limited performance. Our model incorporates an attention mechanism to effectively fuse the information from molecular fingerprints and molecular graphs. Furthermore, we leverage the relationship between drugs and other entities from the knowledge graph to achieve liver toxicity grading. Experimental results demonstrate that our proposed method exhibits highly competitive performance in both DILI/No-DILI and Most-DILI/Less-DILI classification. External validation conducted on an independent set of benchmark drugs yields satisfactory results, demonstrating the robustness of our approach. Additionally, we employ a series of interpretability methods to investigate the relationship between the different types of data utilized by the model and toxicity outcomes. These analyses highlight the interpretability of our method, providing valuable insights and support for drug toxicity evaluation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.